» Articles » PMID: 18266944

The Placenta and Intrauterine Programming

Overview
Specialty Endocrinology
Date 2008 Feb 13
PMID 18266944
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Intrauterine programming is the process by which the structure and function of tissues are altered permanently by insults acting during early development. In mammals, the placenta controls intrauterine development by supplying oxygen and nutrients, and by regulating the bioavailability of specific hormones involved in foetal growth and development. Consequently, the placenta is likely to have a key role in mediating the programming effects of suboptimal conditions during development. This review examines placental phenotype in different environmental conditions and places particular emphasis on regulation of placental nutrient transfer capacity and endocrine function by insults known to cause intrauterine programming. More specifically, it examines the effects of a range of environmental challenges on the size, morphology, blood flow and transporter abundance of the placenta and on its rate of consumption and production of nutrients. In addition, it considers the role of hormone synthesis and metabolism by the placenta in matching intrauterine development to the prevailing environmental conditions. The adaptive responses that the placenta can make to compensate for suboptimal conditions in utero are also assessed in relation to the strategies adopted to maximise foetal growth and viability at birth. Environmentally-induced changes in placental phenotype may provide a mechanism for transmitting the memory of early events to the foetus later in gestation, which leads to intrauterine programming of tissue development long after the original insult.

Citing Articles

Maternal stress during pregnancy alters circulating small extracellular vesicles and enhances their targeting to the placenta and fetus.

Sanchez-Rubio M, Abarzua-Catalan L, Del Valle A, Mendez-Ruette M, Salazar N, Sigala J Biol Res. 2024; 57(1):70.

PMID: 39342314 PMC: 11438166. DOI: 10.1186/s40659-024-00548-4.


Clomiphene Citrate Administered in Periconception Phase Causes Fetal Loss and Developmental Impairment in Mice.

Chin P, Chan H, Kieffer T, Prins J, Russell D, Davies M Endocrinology. 2024; 165(7).

PMID: 38608138 PMC: 11197002. DOI: 10.1210/endocr/bqae047.


Avian extraembryonic membranes respond to yolk corticosterone early in development.

Harders E, Agustin M, Paitz R Biol Open. 2023; 13(1).

PMID: 38156650 PMC: 10836647. DOI: 10.1242/bio.060131.


The associations of gestational weight gain and midpregnancy lipid levels with placental size and placental-to-birth weight ratio: findings from a chinese birth cohort study.

Zhang K, Jia X, Yu W, Cheng X, Li Y, Wang X BMC Pregnancy Childbirth. 2023; 23(1):725.

PMID: 37821857 PMC: 10568921. DOI: 10.1186/s12884-023-05991-x.


Establishment of the fetal-maternal interface: developmental events in human implantation and placentation.

Huang C, Hsueh Y, Chang C, Hsu H, Yang T, Lin W Front Cell Dev Biol. 2023; 11:1200330.

PMID: 37266451 PMC: 10230101. DOI: 10.3389/fcell.2023.1200330.